A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
Saved in:
| Title: | A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study. |
|---|---|
| Authors: | Niger, Monica1 (AUTHOR) Monica.niger@istitutotumori.mi.it, Nichetti, Federico1,2 (AUTHOR), Fornaro, Lorenzo3 (AUTHOR), Pircher, Chiara1 (AUTHOR), Morano, Federica1 (AUTHOR), Palermo, Federica1 (AUTHOR), Rimassa, Lorenza4,5 (AUTHOR), Pressiani, Tiziana5 (AUTHOR), Berardi, Rossana6 (AUTHOR), Gardini, Andrea Casadei7,8 (AUTHOR), Sperti, Elisa9 (AUTHOR), Salvatore, Lisa10,11 (AUTHOR), Melisi, Davide12,13 (AUTHOR), Bergamo, Francesca14 (AUTHOR), Siena, Salvatore15,16 (AUTHOR), Mosconi, Stefania17 (AUTHOR), Longarini, Raffaella18 (AUTHOR), Arcangeli, Giuseppina19 (AUTHOR), Corallo, Salvatore20 (AUTHOR), Delliponti, Laura3 (AUTHOR) |
| Source: | BMC Cancer. 4/8/2024, Vol. 24 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-024-12225-6 |
